Genetic counseling and testing for germline variants in BRCA1 and BRCA2 and in other hereditary breast and/or ovarian cancer (HBOC) susceptibility genes was established when the significance of hereditary cancer screening and preventive measures was recognized. This evidence concerns the gene BRCA1 and ovarian cancer.